Mirtazapin Sandoz 15

Mirtazapin Sandoz 15 is a medicine authorised by Swissmedic under authorisation number 62388. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 October 2011 and the authorisation is valid without a time limit. ATC code N06AX11 places the medicine in the group Psychoanaleptics.

  • Dispensing category B
  • Authorisation number 62388
  • ATC N06AX11
  • Synthetic medicines
Authorisation data
Authorisation number62388
NameMirtazapin Sandoz 15
Full nameMirtazapin Sandoz 15, Filmtabletten
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN06AX11
First authorisation06 October 2011
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Mirtazapin Sandoz 15, FilmtablettenB06 October 2011
2Mirtazapin Sandoz 30, FilmtablettenB06 October 2011
3Mirtazapin Sandoz 45, FilmtablettenB06 October 2011

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110Tablette(n)N06AX1101.06.0.B
230Tablette(n)N06AX1101.06.0.B
3100Tablette(n)N06AX1101.06.0.B
430Tablette(n)N06AX1101.06.0.B
5100Tablette(n)N06AX1101.06.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Mirtazapin Sandoz 15 authorised in Switzerland?

Yes. Mirtazapin Sandoz 15 is authorised by Swissmedic under authorisation number 62388, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Mirtazapin Sandoz 15 have?

Mirtazapin Sandoz 15 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Mirtazapin Sandoz 15?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com